You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

interleukin-6 antagonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Interleukin-6 Antagonists in Critically-ill Covid-19 Patients

Not yet recruiting
  • COVID-19
  • Critical Illness
  • IL6 Antagonist
  • (no location specified)
Jan 29, 2022

Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)

Completed
  • Intracerebral Haemorrhage
  • IL-1Ra Kineret®
  • IL-1Ra Placebo
  • Manchester, North West, United Kingdom
    Salford Royal NHS Foundation Trust
Oct 4, 2021

Anti-IL6 and Corticosteroid Monotherapy vs Combination in

Recruiting
  • Critical Illness
  • +2 more
  • Interleukin 6 (IL6) Antagonist
  • +2 more
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital and Research Center
Mar 4, 2021

Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)

Recruiting
  • Subarachnoid Hemorrhage
  • Plymouth, Devon, United Kingdom
  • +11 more
May 16, 2022

Interleukin 6 Receptor Antagonists in Corona Virus Disease 19

Recruiting
  • Corona Virus Infection
  • ELISA
  • Assiut, Egypt
    AssiutU
Feb 2, 2023

Netosis During COVID-19, Under Treatment With

Active, not recruiting
  • Covid19
    • Paris, France
    • +1 more
    Mar 30, 2022

    Burnout Syndrome, Neutrophil-Lymphocyte Ratio, Interleukin-6 Trial (music therapy)

    Not yet recruiting
    • Burnout Syndrome
    • +3 more
    • music therapy
    • (no location specified)
    Feb 20, 2023

    NEONATAL SEPSIS Trial in Sohag (INTERLEUKIN 6)

    Not yet recruiting
    • NEONATAL SEPSIS
    • INTERLEUKIN 6
    • Sohag, Egypt
      Sohag University hospitals
    Oct 18, 2022

    Autoantibodies, Interleukin-6 Trial in Frederiksberg (Oral Glucose Tolerance Test, Cycling test)

    Recruiting
    • Autoantibodies
    • Interleukin-6
    • Oral Glucose Tolerance Test
    • Cycling test
    • Frederiksberg, Denmark
      Frederiksberg Hospital
    May 10, 2023

    Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

    Not yet recruiting
    • Pericarditis
    • IL1RA Antibody Assay
    • suPAR Testing
    • Homburg, Germany
    • +8 more
    Jun 22, 2023

    Healthy Trial in Qingdao (VDJ001, Placebo)

    Completed
    • Healthy
    • Qingdao, Shandong, China
      the Affliated Hospital of Qingdao University
    Aug 30, 2023

    Arthritis, Rheumatoid, Interaction Trial in Esbjerg, Odense, Sønderborg (Tocilizumab, Sarilumab)

    Terminated
    • Arthritis, Rheumatoid
    • Interaction
    • Esbjerg, Region Of Southern Denmark, Denmark
    • +2 more
    Jan 20, 2023

    Inflammatory Response, Periodontitis Trial in Istanbul (Samples collection and ELISA analyses, Evaluating periodontal

    Completed
    • Inflammatory Response
    • Periodontitis
    • Samples collection and ELISA analyses
    • Evaluating periodontal paramètres
    • Istanbul, Turkey
      Istanbul Medipol University, School of Dentistry
    Jul 23, 2022

    Cancers Among Diabetics ,Observational Study

    Enrolling by invitation
    • Cancer
    • +3 more
    • interleukin 6
    • Riyadh, N/A (Non-US), Saudi Arabia
      ministry of health , First health cluster , Riaydh
    Oct 28, 2022

    Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor

    Completed
    • Early Childhood Caries
    • ELISA
    • Aydın, Turkey
      Sultan KELEŞ
    Oct 20, 2021

    Chronic Obstr Lung Disease Trial in Cairo (interleukin 6)

    Completed
    • Chronic Obstr Lung Disease
    • interleukin 6
    • Cairo, Egypt
      Beni Suef university
    Jan 27, 2022

    Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

    Recruiting
    • Idiopathic Multicentric Castleman's Disease
    • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
    • +2 more
    • Beijing, China
    • +2 more
    Apr 26, 2022

    Beta Endorphins,Interleukin 1 and Interleukin 38 in Covid

    Recruiting
    • Covid Patients
    • βeta endorphins, interleukin 6 and interleukin 38
    • Assiut, Egypt
      Assiut university
    Jan 22, 2022

    COPD Exacerbation Acute, Ascaris Lumbricoides Infection, Chronic Pulmonary Aspergillosis Trial (Interleukin-1B, Interleukin-4,

    Not yet recruiting
    • COPD Exacerbation Acute
    • +2 more
    • Interleukin-1B
    • +4 more
    • (no location specified)
    Mar 23, 2023

    Serum Interleukin 6 and 8 in Children With Acute Gastroenteritis

    Recruiting
    • Acute Gastroenteritis
    • Acute Diarrhea
    • Evaluation of serum levels of IL-6 and IL-8
    • Sohag, Egypt
      Sohag University Hospital
    Jan 15, 2022

    Rheumatoid Arthritis Trial in Copenhagen (Exercise, No exercise)

    Recruiting
    • Rheumatoid Arthritis
    • Exercise
    • No exercise
    • Copenhagen, Denmark
      Rigshospitalet
    Feb 3, 2022

    Acute Myeloid Leukemia, Vitamin D Deficiency, ADAMTS13 Trial in Cairo (Cholecalciferol 2800 I.U. ml oral drops)

    Completed
    • Acute Myeloid Leukemia
    • +3 more
    • Cholecalciferol 2800 I.U. ml oral drops
    • Cairo, Madinaty, Egypt
      Dina Ashraf Abdelhady
    Nov 25, 2021

    Sepsis, Severe Trial (probiotics( Lactobacillus acidophilus, lactobacillus delbruekii and lactobacillus fermentum 10 billions),,

    Not yet recruiting
    • Sepsis, Severe
    • probiotics( Lactobacillus acidophilus, lactobacillus delbruekii and lactobacillus fermentum 10 billions),
    • maltose dissolved in distilled water
    • (no location specified)
    Jul 18, 2022

    Adverse Effect Trial (normal saline, Ondansetron 4 mg, Ondansetron 8 mg)

    Not yet recruiting
    • Adverse Effect
    • normal saline
    • +2 more
    • (no location specified)
    Jul 25, 2022

    Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

    Active, not recruiting
    • Multiple Myeloma
    • AL Amyloidosis
    • Siltuximab
    • The M.D. Anderson Symptom Inventory (MDASI)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 23, 2023